ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ)
$3.1 0 (0%)
Analysed ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) News Sources
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results
19-03-2026
yahoo.com
Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at UChicago Medicine
16-03-2026
yahoo.com
Eledon Pharmaceuticals Touts Tegoprubart Safety in BESTOW Kidney Transplant Data at Leerink Conference
15-03-2026
marketbeat.com
Eledon Pharmaceuticals Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Liver Transplantation
10-03-2026
yahoo.com
NewcelX and Eledon partner for NCEL-101 programme
10-03-2026
hospitalmanagement.net
NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes
09-03-2026
yahoo.com
Eledon Pharmaceuticals to Participate in Leerink Partners 2026 Global Healthcare Conference
04-03-2026
yahoo.com
Eledon Pharmaceuticals Highlights BESTOW Data, Phase III Plans and FDA Timeline for “Tego” at Conference
13-02-2026
marketbeat.com
Eledon Pharmaceuticals to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
05-02-2026
yahoo.com
Eledon Pharmaceuticals Presents Long-Term Phase 1b Data for Tegoprubart in Kidney Transplant Patients at the American Society of Transplant Surgeons Winter Symposium
23-01-2026
yahoo.com
What is the current price of ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ)?
The current price of ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) is $3.1.
ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) absolute price change since previous trading day?
The absolute price change of ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) since the previous trading day is $0.
ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) percentage price change since previous trading day?
The percentage price change of ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) since the previous trading day is 0%.
What is the most recent average sentiment score for ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ)?
The most recent average sentiment score for ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ)?
The most recent sentiment for ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) is .
SEC-8K** Filing Available For ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.